Rainer Riedl

Prof. Dr. Rainer Riedl is the Head of the Competence Center for Drug Discovery and Organic & Medicinal Chemistry at the Zurich University of Applied Sciences (School of Life Sciences and Facility Management). He leads numerous drug development projects targeting acute myeloid leukemia, Alzheimer's disease, antimicrobial resistance, and infectious diseases, with a focus on peptide therapeutics, targeted protein degradation, and structure-based drug design.

His research combines medicinal chemistry and natural product-inspired design to develop antiviral agents (including against SARS-CoV-2), anti-inflammatory compounds, and novel antimicrobial delivery systems using extracellular vesicles. He has pioneered computational frameworks like CyBy2 for chemical data management and contributed to inhibitor development for matrix metalloproteinases and SENPs.

Recent peer-reviewed publications highlight his work in drug resistance mechanisms, peptide engineering, and innovative antiviral strategies. He holds multiple international patents for CD93 inhibitors, skin cancer treatments, and antifungal compounds, reflecting translational impact of his research.